Savicell
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Matam Advanced Technology Park, Haifa, H...Website
www.savicell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Savicell
SAVICELL LTD, known as the Immunobiopsy Company, specializes in early disease detection through its Savicell Well-Shield platform, a blood test aimed primarily at identifying cancer. The technology leverages the body's immune response to detect disease intrusion and cell malformation. By interpreting differential metabolic responses, the platform enhances the early diagnosis of malignancies. Their intended clients include healthcare providers and patients seeking advanced diagnostic solutions.Explore more
Savicell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Savicell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Savicell launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Savicell had a recent Job posting/layoffs
Check if Savicell has recently received funding, and reach out quickly before it becomes old news!
Check out if Savicell is spiking on competitors!
Savicell, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Savicell has new funding data
Congratulate Masked Content for being promoted to Masked Content at Savicell
Earning: See what the market has to say on Savicell recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Savicell as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Savicell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Savicell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Savicell.
Savicell Tech Stack
A closer look at the technologies used by Savicell
See more technologies
Savicell News & Media
Online Disruptive Technologies adds South Korea to its patent portfolio
LAS VEGAS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Online Disruptive Technologies, Inc. (OTC PINK:ONDR) (the "Company") is pleased to announce that its subsidiary, Savicell Diagnostic Ltd. (“Savicell”) was granted a patent in South Korea in August 2019 - Title: METHODS OF MONITORING AND ANALYZING METABOLIC ACTIVITY PROFILES DIAGNOSTIC AND THERAPEUTIC USES OF SAME. The South Korean patent complements similar patents already granted in this regard by the United States, Europe, China, Japan, CanadaOnline Disruptive Technologies Announces Publication of Results in Cancer Journal
LAS VEGAS, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Online Disruptive Technologies, Inc. (OTC PINK:ONDR) (the "Company") is pleased to announce that its lung cancer clinical study results were published in the scientific journal Cancer Immunology and Immunotherapy. The results as published clearly validate the promise of Savicell’s Liquid ImmunoBiopsy™. The published study uses the Savicell Diagnostics, Ltd. platform to diagnose lung cancer, producing 91% sensitivity and 80% specificity in a 20-fold c
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Savicell
Sign Up For FreeTo access detailed company insights
SAVICELL LTD, known as the Immunobiopsy Company, specializes in early disease detection through its Savicell Well-Shield platform, a blood test aimed primarily at identifying cancer. The technology leverages the body's immune response to detect disease intrusion and cell malformation. By interpreting differential metabolic responses, the platform e... Read More
